NCT01951755View on ClinicalTrials.gov

Phase IV Study of Tarceva in Patients With Advanced Stage IIIB/ IV Non-small Cell Lung Cancer (NSCLC)

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Non-small Cell Lung Cancer
Trial Locations (1)

115 27

Oncology Unit Sotiria Hospital of Chest Diseases, Athens

All Listed Sponsors
lead

University of Athens

OTHER

NCT01951755 - Phase IV Study of Tarceva in Patients With Advanced Stage IIIB/ IV Non-small Cell Lung Cancer (NSCLC) | Biotech Hunter | Biotech Hunter